Position in BBIO
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$2,356,025
-$359,663 QoQ
Shares Held
31,633
-13.5% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#186
of 469 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Qsemble Capital Management, LP holds $7,848,553 across 6 Biotechnology names. BBIO ranks #1 (30.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
This page
|
31,633 | $2,356,025 | |
| 2 | INSM |
INSMED Inc
|
21,148 | $2,254,799 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
|
47,971 | $1,871,348 | |
| 4 | RPRX |
Royalty Pharma plc
|
10,675 | $598,547 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
5,639 | $459,634 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
3,887 | $308,200 |
All Filings in BBIO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,356,025 | 31,633 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $2,715,688 | 36,570 | Shares | Sole | 2026-05-07 | |
| 2025-09-30 | $2,873,320 | 55,320 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,828,457 | 42,345 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,472,612 | 42,598 | Shares | Sole | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||